Transcatheter Tricuspid Valve Replacement (TTVR) with VDyne TriNova System for tricuspid valve insufficiency

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 8 Apr 2026: Trial registered, NCT07516444

The trials

NCT07516444: VDyne TriNova Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)

State
Under way
Phase
No phase
People
520 planned
Started
28 Jul 2026
Primary completion
Jun 2029
Arms
Randomized cohort VDyne TriNova TTVR, Single Arm Registry
Results
None posted
  1. 8 Apr 2026: Trial registered
  2. 28 Jul 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Device.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.